July 6, 2023 Worldwide collaborative framework for optimizing new Parkinson’s treatment trials with patient centric outcome measures
June 15, 2023 US and UK policy responses to the challenges of repurposing approved drugs for new indications
Podcast: Sharing Data to Improve Patient-Focused Outcomes Critical Path Institute’s Dr. Diane Stephenson joined host Alaina Webster to discuss the importance of data sharing to improve..
May 3, 2023 Video: Brief TRxA Overview In this video, TRxA Executive Director Maaike Everts and Associate Director Michelle Morgan give viewers a short overview of the..
March 15, 2023 Critical Path for Rare Neurodegenerative Diseases (CP-RND): An Introduction to the Patient Community Thank you for your interest in the recent webinar, Critical Path for Rare Neurodegenerative Diseases (CP-RND): An Introduction...
The Rare Disease Clinical Outcome Assessment Consortium: Aiming to Fulfill Unmet Drug Development Endpoint Measurement Needs Appropriate endpoint selection for rare disease trials is challenging. The Rare Disease Clinical Outcome Assessment (COA)....
February 8, 2023 TRxA 2023 Funding Opportunities C-Path's Translational Therapeutics Accelerator is a global drug discovery support program...
Using Real World Data from CURE ID to Identify Drug Repurposing Opportunities in Mycology: Impact of Climate Change
